Price target
7.000.000.00%
The 3 analysts offering 1 year price forecasts for IKT have a max estimate of — and a min estimate of —.
Analyst rating
Based on 3 analysts giving stock ratings to IKT in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
IKT EPS for the last quarter is −0.66 USD despite the estimation of −0.67 USD. In the next quarter EPS is expected to reach −0.48 USD. Track more of Inhibikase Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Inhibikase Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Inhibikase Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, IKT price target is 7.00 USD with a max estimate of 8.00 USD and a min estimate of 5.00 USD. Check if this forecast comes true in a year, meanwhile watch Inhibikase Therapeutics, Inc. stock price chart and keep track of the current situation with IKT news and stock market news.